|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0494 USD | +90.00% |
|
+71.53% | +147.00% |
| Market Cap | 5.07M 3.61M 3.14M 2.92M 2.68M 345M 5.15M 34.38M 13.48M 172M 13.58M 13.28M 569M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.75M 5.86M 5.45M 5.01M 644M 9.62M 64.21M 25.18M 321M 25.36M 24.8M 1.06B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +90.00% | ||
| 1 week | +71.53% | ||
| 1 month | +52.00% | ||
| 3 months | -23.88% | ||
| 6 months | +394.00% | ||
| Current year | +147.00% |
| 1 week | 0.02 | 0.05 | |
| 1 month | 0.01 | 0.05 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.17 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 2017-09-21 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 2015-03-09 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 2018-05-16 |
Benjamin Higham
BRD | Director/Board Member | - | 2020-04-07 |
Jakob Ripshtein
BRD | Director/Board Member | 60 | 2020-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/23 | Buy | Director | 30,000 | 0.0274% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% | ||
| 12/17/23 | Buy | Director | 500 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +90.00% | +71.53% | -9.52% | -70.94% | 5.42M | ||
| +2.44% | +2.02% | +23.35% | +7.11% | 1.58B | ||
| -3.74% | -4.89% | +71.71% | +211.44% | 811M | ||
| -0.67% | -2.62% | -1.66% | +72.67% | 186M | ||
| -4.11% | -5.41% | +25.00% | -62.16% | 154M | ||
| +1.42% | +4.38% | +39.85% | -47.81% | 82.05M | ||
| Average | +14.22% | +9.97% | +24.79% | +18.39% | 469.02M | |
| Weighted average by Cap. | +0.23% | -0.49% | +36.14% | +64.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 9.83M 8.54M 7.94M 7.3M 939M 14.03M 93.6M 36.71M 468M 36.96M 36.15M 1.55B | 14.25M 10.16M 8.82M 8.2M 7.54M 969M 14.49M 96.66M 37.91M 483M 38.17M 37.34M 1.6B |
| Net income | -1.49M -1.06M -924K -859K -790K -102M -1.52M -10.13M -3.97M -50.6M -4M -3.91M -168M | -2.69M -1.92M -1.67M -1.55M -1.42M -183M -2.74M -18.25M -7.16M -91.21M -7.21M -7.05M -302M |
| Net Debt | 5.66M 4.03M 3.5M 3.26M 2.99M 385M 5.75M 38.38M 15.05M 192M 15.16M 14.83M 635M | 4.4M 3.13M 2.72M 2.53M 2.33M 299M 4.47M 29.83M 11.7M 149M 11.78M 11.52M 494M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | US$0.0494 | +90.00% | 61,281 |
| 26-07-29 | US$0.0260 | -3.35% | 39,000 |
| 26-07-28 | US$0.0269 | -6.60% | 10,000 |
| 26-07-24 | US$0.0288 | -3.03% | 3,000 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















